These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4898006)

  • 41. Histochemical fluorescence detection of changes in central monoamine neurones provoked by drugs acting on the CNS.
    Fuxe K; Hökfelt T
    Triangle; 1971; 10(3):73-84. PubMed ID: 5138525
    [No Abstract]   [Full Text] [Related]  

  • 42. [Biogenic amines in receptor organs of gastropods (Prosobranchia, Opisthobranchia)].
    Storch V
    Z Zellforsch Mikrosk Anat; 1971; 115(1):94-9. PubMed ID: 4929634
    [No Abstract]   [Full Text] [Related]  

  • 43. Dopamine in substantia nigra and cortex after gamma-butyrolactone treatment.
    Pericić D; Walters JR
    J Pharm Pharmacol; 1976 Jun; 28(6):527-30. PubMed ID: 7658
    [No Abstract]   [Full Text] [Related]  

  • 44. [Pharmaco-biochemical mechanisms and modern therapy in Parkinsonian syndromes].
    Bartholini G; Tissot R
    Rev Med Liege; 1970 Sep; 25(18):591-607. PubMed ID: 5511964
    [No Abstract]   [Full Text] [Related]  

  • 45. [The strio-pallidal system and its accessory mechanisms in relation to extra-pyramidal physiopathology].
    Poirier LJ
    Presse Med (1893); 1970 Jun; 78(31):1395-401. PubMed ID: 4987846
    [No Abstract]   [Full Text] [Related]  

  • 46. Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons.
    Uhl GR; Walther D; Mash D; Faucheux B; Javoy-Agid F
    Ann Neurol; 1994 Apr; 35(4):494-8. PubMed ID: 8154880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between animal models and clinical parkinsonism.
    Marsden CD; Duvoisin RC; Jenner P; Parkes JD; Pycock C; Tarsy D
    Adv Neurol; 1975; 9():165-75. PubMed ID: 1146651
    [No Abstract]   [Full Text] [Related]  

  • 48. Ultrastructural cytochemistry and pharmacology of 5-hydroxytryptamine in adrenergic nerve endings. II. Accumulation of 5-hydroxytryptamine in nerve vesicles containing norepinephrine in rat vas deferens.
    Zieher LM; Jaim-Etcheverry G
    J Pharmacol Exp Ther; 1971 Jul; 178(1):30-41. PubMed ID: 5087403
    [No Abstract]   [Full Text] [Related]  

  • 49. Central monoaminergic pathways with emphasis on their relation to the so called 'extrapyramidal motor system'.
    Fuxe K; Hökfelt T; Olson L; Ungerstedt U
    Pharmacol Ther B; 1977; 3(2):169-210. PubMed ID: 413120
    [No Abstract]   [Full Text] [Related]  

  • 50. Cyclic variations of catecholamine content in hypothalamic nerve cells during the estrous cycle of the rat, with a concomitant study of the substantia nigra.
    Lichtensteiger W
    J Pharmacol Exp Ther; 1969 Feb; 165(2):204-15. PubMed ID: 5812578
    [No Abstract]   [Full Text] [Related]  

  • 51. The molecular mechanisms of dopamine toxicity.
    Barzilai A; Daily D; Zilkha-Falb R; Ziv I; Offen D; Melamed E; Shirvan A
    Adv Neurol; 2003; 91():73-82. PubMed ID: 12442665
    [No Abstract]   [Full Text] [Related]  

  • 52. The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system.
    Herrera AJ; Castaño A; Venero JL; Cano J; Machado A
    Neurobiol Dis; 2000 Aug; 7(4):429-47. PubMed ID: 10964613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of 6-hydroxydopamine pretreatment on the accumulation of dopa and dopamine in brain and peripheral organs following L-dopa administration.
    Lytle LD; Hurko O; Romero JA; Cottman K; Leehey D; Wurtman RJ
    J Neural Transm; 1972; 33(1):63-71. PubMed ID: 4641868
    [No Abstract]   [Full Text] [Related]  

  • 54. [Ultrastructural autoradiography of the metabolism of biogenic amines in the gastrointestinal tract and in other organs].
    Forssmann WG; Wacker P; Daldrup J
    Verh Anat Ges; 1971; 65():19-29. PubMed ID: 5317021
    [No Abstract]   [Full Text] [Related]  

  • 55. Uptake of dopamine by rat mast cells in vivo.
    Enerbäck L; Häggendal J
    Pathol Eur; 1970; 5(4):401-8. PubMed ID: 5515046
    [No Abstract]   [Full Text] [Related]  

  • 56. [Histochemical study of the effect of drugs on the uptake of alpha-methylnoradrenaline by noradrenaline and dopamine containing neurones in rats treated with reserpine].
    Lorez HP
    Z Gesamte Exp Med Einschl Exp Chir; 1969; 151(3):241-60. PubMed ID: 5358460
    [No Abstract]   [Full Text] [Related]  

  • 57. Dopamine action and disorders of neurotransmitter balance.
    Birkmayer W; Birkmayer JD
    Gerontology; 1987; 33(3-4):168-71. PubMed ID: 3653699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental midbrain lesions: neurochemical comparison between the animal model and Parkinson's disease.
    Hockman CH; Lloyd KG; Farley IJ; Hornykiewicz O
    Brain Res; 1971 Dec; 35(2):613-8. PubMed ID: 5135560
    [No Abstract]   [Full Text] [Related]  

  • 59. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
    Pletscher A; Bartholini G; Gey KF; Jenni A
    Schweiz Med Wochenschr; 1970 May; 100(19):797-804. PubMed ID: 4924275
    [No Abstract]   [Full Text] [Related]  

  • 60. [Localization of biogenic amines in the rat spinal cord. A fluorescence histochemical study after intraventricular injection of L-dopa (author's transl)].
    Chouchkov CN
    Histochemistry; 1974; 41(2):167-73. PubMed ID: 4374457
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.